TMEM74B Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-47770
Key Product Details
Species Reactivity
Human, Mouse
Applications
ELISA, Immunohistochemistry
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
chromosome 20 open reading frame 46. (Uniprot# Q9NUR3)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
Novus Biologicals Rabbit TMEM74B Antibody - BSA Free (NBP3-47770) is a polyclonal antibody validated for use in IHC and ELISA. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for TMEM74B Antibody - BSA Free
Immunohistochemistry: TMEM74B Antibody - BSA Free [NBP3-47770] -
Immunohistochemistry: TMEM74B Antibody - BSA Free [NBP3-47770] - Immunohistochemistry of paraffin-embedded human colon cancer tissue slide using ( TMEM74B Antibody) at dilution of 1:50Applications for TMEM74B Antibody - BSA Free
Application
Recommended Usage
Immunohistochemistry
1:20-1:200
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS, 50% Glycerol, pH (7.3)
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: TMEM74B
Alternate Names
C20orf46, chromosome 20 open reading frame 46, FLJ11190, transmembrane protein 74B, transmembrane protein C20orf46
Gene Symbol
TMEM74B
Additional TMEM74B Products
Product Documents for TMEM74B Antibody - BSA Free
Product Specific Notices for TMEM74B Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...